Results 191 to 200 of about 293,895 (310)

MUCOUS COLITIS. [PDF]

, 1907
J. C. Simpson, P. Lockhart Mummery
openalex   +1 more source

Deciphering the catalytic and pharmacological mechanisms of Coptis chinensis herbzymes to renovate intestinal microenvironment for colitis alleviation

BMEMat, EarlyView.
The synthesized CCzymes possess both antioxidant enzyme activity and pharmacological properties inherent to Coptis chinensis. By their antioxidant enzyme activity, CCzymes can attenuate oxidative stress within the inflammatory region of ulcerative colitis (UC), while their pharmacological activity acts on macrophage polarization and the intestinal ...
Zhichao Deng, Can Li, Yujie Zhang, Yuanyuan Zhu, Chenxi Xu, Bowen Gao, Mingxin Zhang, Martina H. Stenzel, Kelong Fan, Mingzhen Zhang, Yanyan Jiang   +10 more
wiley   +1 more source

Effect of Chang'an decoction on ulcerative colitis by regulating T helper 17 cells and regulatory T cellsRab27 in the p53/high mobility group box 1 pathway. [PDF]

J Tradit Chin Med
Li Z, Ting J, Xiaojing W, Yingqi W, Fengbin L, Hong MI.   +5 more
europepmc   +1 more source

Colitis Polyposa [PDF]

, 1904
F. Pope
openalex   +1 more source

Mechanism and role of regulated cell death in tumor immunity and immunotherapy

Cancer Communications, EarlyView.
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu, Yan Li, Bingjie Lian, Yitao Mao, Luqing Zhao   +4 more
wiley   +1 more source

Meeting Report: Research Topics in Gastrointestinal Disease VIII

Canadian Journal of Gastroenterology, 2009
Gordon R Greenberg, Ken Croitoru, Stephen Vanner, George Tolomiczenko, Louise Hope   +4 more
doaj   +1 more source

Research Trends and Hotspots in JAK Inhibitors for Ulcerative Colitis: A Bibliometric Analysis From 2015 to 2024. [PDF]

J Multidiscip Healthc
Wang Y, Wang Z, Lou P, Ni H, Yang Y, Chen G, Zhang S.   +6 more
europepmc   +1 more source

Ulcerative Colitis [PDF]

, 1909
G. H. Makins
openalex   +1 more source

Gankyrin‐Protein Interactions in GI Cancers: A Novel Target of New Therapeutics

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Gankyrin (PSMD10) is a 25 kDa oncogenic protein and regulatory subunit of the 26S proteasome, characterized by a sevenfold ankyrin repeat domain. Gankyrin is overexpressed in various malignancies, particularly gastrointestinal (GI) cancers. Gankyrin contributes to tumorigenesis by modulating key signaling pathways and engaging in oncogenic ...
Shuang Li, Yuky Lam, Aaron Muth, Zhe‐Sheng Chen, Shanzhi Wang   +4 more
wiley   +1 more source

Impact of ERAP1 downregulation on the pathogenesis of DSS-induced colitis and therapeutic response to sulfasalazine. [PDF]

Front Immunol
Riaz B, Ryu HM, Islam SMS, Babita R, Seong JK, Lee H, Lee EH, Sohn S.   +7 more
europepmc   +1 more source